Using an integrated care pathway to deliver a nurse-led clozapine clinic

International Journal of Care Pathways

Volumn 8, Issue 3, 2004, Pages 114-118

  Chave, Jo ^a   Painter, Jon ^a   Peet, Malcolm ^a   Wakefield, Susan ^b  

^a ROTHERHAM DONCASTER AND SOUTH HUMBER NHS FOUNDATION TRUST   (United Kingdom)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

AGRANULOCYTOSIS; ARTICLE; BLOOD SAMPLING; HEALTH CARE DELIVERY; HEALTH SERVICE; HUMAN; MEDICAL RECORD; MEDICAL STAFF; OUTPATIENT DEPARTMENT; PATIENT CARE; PATIENT EDUCATION; PATIENT MONITORING; PRACTICE GUIDELINE; SCHIZOPHRENIA; STAFF TRAINING;

EID: 11144298984     PISSN: 20404026     EISSN: None     Source Type: Journal    
DOI: 10.1177/147322970400800304     Document Type: Article

References (8)

1. Johnson S. Variance tracking from an effective pathway process. Health Care Risk Report 1997/98; 4: 1–6
2. Johnson S. Use of ICPs to manage unpredictable situations. Professional Nurse 2000; 16: 956–8
3. National Institute for Clinical Excellence. Guidance on the use of newer (atypical) antipsychotic drugs for the treatment of schizophrenia. Technology Appraisal Guidance No. 43. London: NICE, 2002
4. British Medical Association. British national formulary. London: Pharmaceutical Press, 2004
5. Camprubi M, Bagary M, Riccio M. The clozapine clinic. Lancet 1996; 347: 124
6. Peet M, Wakefield S. Integrated care pathways in mental health: The need for the human touch. Journal of Integrated Care Pathways 2002; 6: 108–14
7. de Luc K. Care pathways: An evaluation of their effectiveness. Journal of Advanced Nursing 2000; 32: 485–96
8. Wakefield S, Peet M. Developing integrated care pathways in mental health: The critical success factors. Journal of Integrated Care Pathways 2003; 7: 47–49